Drugs / Hyperpolarized Xenon gas
Hyperpolarized Xenon gas
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03482960 | May 2018 → Apr 2019 | cystic fibrosis | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hyperpolarized Xenon gas | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03482960 ↗ |
| Modality | Diagnostic / imaging agent | “hyperpolarized xenon MRI” NCT03482960 ↗ |
| Route | Inhaled | “self-administer hyperpolarized xenon gas via inhalation” NCT03482960 ↗ |